131 related articles for article (PubMed ID: 8535343)
1. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand.
Moerlein SM; Perlmutter JS; Welch MJ
Nucl Med Biol; 1995 Aug; 22(6):809-15. PubMed ID: 8535343
[TBL] [Abstract][Full Text] [Related]
2. Specific binding of 3N-(2'-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET.
Moerlein SM; Perlmutter JS
Neurosci Lett; 1992 Dec; 148(1-2):97-100. PubMed ID: 1300511
[TBL] [Abstract][Full Text] [Related]
3. In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding.
Moerlein SM; Perlmutter JS; Markham J; Welch MJ
J Cereb Blood Flow Metab; 1997 Aug; 17(8):833-45. PubMed ID: 9290581
[TBL] [Abstract][Full Text] [Related]
4. Central serotonergic S2 binding in Papio anubis measured in vivo with N-omega-[18F]fluoroethylketanserin and PET.
Moerlein SM; Perlmutter JS
Neurosci Lett; 1991 Feb; 123(1):23-6. PubMed ID: 2062450
[TBL] [Abstract][Full Text] [Related]
5. Binding of 5-(2'-[18F]fluoroethyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography.
Moerlein SM; Perlmutter JS
Eur J Pharmacol; 1992 Jul; 218(1):109-15. PubMed ID: 1327820
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor-mediated regulation of striatal cholinergic activity: positron emission tomography studies with norchloro[18F]fluoroepibatidine.
Ding YS; Logan J; Bermel R; Garza V; Rice O; Fowler JS; Volkow ND
J Neurochem; 2000 Apr; 74(4):1514-21. PubMed ID: 10737608
[TBL] [Abstract][Full Text] [Related]
7. In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.
Suehiro M; Dannals RF; Scheffel U; Stathis M; Wilson AA; Ravert HT; Villemagne VL; Sanchez-Roa PM; Wagner HN
J Nucl Med; 1990 Dec; 31(12):2015-21. PubMed ID: 2148346
[TBL] [Abstract][Full Text] [Related]
8. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding.
Moerlein SM; Banks WR; Parkinson D
Int J Rad Appl Instrum A; 1992 Jul; 43(7):913-7. PubMed ID: 1321101
[TBL] [Abstract][Full Text] [Related]
9. Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding.
Perlmutter JS; Moerlein SM; Hwang DR; Todd RD
J Neurosci; 1991 May; 11(5):1381-9. PubMed ID: 1827499
[TBL] [Abstract][Full Text] [Related]
10. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals.
Nikolaus S; Larisch R; Beu M; Hamacher K; Forutan F; Vosberg H; Müller HW
J Nucl Med; 2003 Apr; 44(4):618-24. PubMed ID: 12679408
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG
Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895
[TBL] [Abstract][Full Text] [Related]
12. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.
Eisenstein SA; Koller JM; Piccirillo M; Kim A; Antenor-Dorsey JA; Videen TO; Snyder AZ; Karimi M; Moerlein SM; Black KJ; Perlmutter JS; Hershey T
Synapse; 2012 Sep; 66(9):770-80. PubMed ID: 22535514
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.
Arnett CD; Shiue CY; Wolf AP; Fowler JS; Logan J; Watanabe M
J Neurochem; 1985 Mar; 44(3):835-44. PubMed ID: 2579198
[TBL] [Abstract][Full Text] [Related]
14. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains.
Ekesbo A; Torstenson R; Hartvig P; Carlsson A; Sonesson C; Waters N; Tedroff J; Långström B
Neuropharmacology; 1999 Mar; 38(3):331-8. PubMed ID: 10219971
[TBL] [Abstract][Full Text] [Related]
15. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.
Logan J; Wolf AP; Shiue CY; Fowler JS
J Neurochem; 1987 Jan; 48(1):73-83. PubMed ID: 2432176
[TBL] [Abstract][Full Text] [Related]
16. [18F]haloperidol binding in baboon brain in vivo.
Yousef KA; Fowler JS; Volkow ND; Dewey SL; Shea C; Schlyer DJ; Gatley SJ; Logan J; Wolf AP
Nucl Med Biol; 1996 Jan; 23(1):47-52. PubMed ID: 9004914
[TBL] [Abstract][Full Text] [Related]
17. Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756.
Boy C; Klimke A; Holschbach M; Herzog H; Mühlensiepen H; Rota Kops E; Sonnenberg F; Gaebel W; Stöcklin G; Markstein R; Müller-Gärtner HW
Synapse; 1998 Dec; 30(4):341-50. PubMed ID: 9826226
[TBL] [Abstract][Full Text] [Related]
18. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
[TBL] [Abstract][Full Text] [Related]
19. Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates.
Moerlein SM; Perlmutter JS; Cutler PD; Welch MJ
Nucl Med Biol; 1997 May; 24(4):311-8. PubMed ID: 9257329
[TBL] [Abstract][Full Text] [Related]
20. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.
Antenor-Dorsey JA; Markham J; Moerlein SM; Videen TO; Perlmutter JS
Nucl Med Biol; 2008 Apr; 35(3):335-41. PubMed ID: 18355689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
